Company intelligence / Profile preview

Immunostep

Salamanca, Castille and Leon, Spainimmunostep.com ↗

Ownership: Private
Development stage: Commercial

Overview

Immunostep develops and commercializes flow cytometry reagents, diagnostic kits, and enabling technologies for research and clinical diagnostics. Their portfolio includes CE-marked IVDs as well as RUO kits. They have developed serological tests for SARS-CoV‑2 and are advancing new solutions in exosome detection. Some pipeline diagnostics are at the registration or clinical validation stage.

Therapeutic areas: OncologyRare DiseasesImmunologyHematologyCardiovascularInfectious Diseases
Modalities: AntibodyRecombinant proteinProtein array
Industry: Protein Biomarker Diagnostics

Partnerships

Technology licensing partners worldwideCollaborations with global scientific communityNo major pharma partnerships publicly listed

Beyond the preview

Go deeper on Immunostep.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunostep.

Explore the full profile